VDRL, CSF
Test Codes
Antrim #30938, EPIC: LAB1231285, SOFT: CVDRL
Department
Immunology
Specimen Collection Criteria
Collect: Cerebrospinal fluid (CSF) in sterile collection container. (Minimum: 0.5 mL)
Send specimen to the Laboratory immediately for processing.
Physician Office/Draw Specimen Preparation
Arrange for transportation to the Laboratory prior to specimen collection. Refrigerate (2-8°C or 36-46°F) specimen immediately after collection and maintain refrigerated prior to transport. (Minimum: 0.5 mL)
Preparation for Courier Transport
Transport: CSF in a sterile collection container, refrigerated (2-8°C or 36-46°F). (Minimum: 0.5 mL)
Rejection Criteria
Specimens not collected and processed as indicated.
Inpatient Specimen Preparation
Transport specimen to the Laboratory immediately after collection. (Minimum: 0.5 mL)
In-Lab Processing
Maintain specimen refrigerated (2-8°C or 36-46°F) if not analyzed immediately.
Storage
Specimen Stability for Testing:
Room Temperature (20-26°C or 68-78.8°F): Unacceptable
Refrigerated (2-8°C or 36-46°F): 5 days
Frozen (-20°C/-4°F or below): 1 year
Specimen Storage in Department Prior to Disposal:
Refrigerated (2-8°C or 36-46°F): 30 days
Laboratory
Royal Oak Special Testing Laboratory
Performed
Monday, Thursday.
Results available within 3 business days.
Reference Range
Non-Reactive.
Test Methodology
Flocculation.
Interpretation
In neurosyphilis, the spinal fluid is reactive in all cases of general paresis but in only 70% of tabes dorsalis cases. In latent syphilis, the spinal fluid is sometimes positive when the serum is non-reactive.
Clinical Utility
VDRL tests are not absolutely specific but they are practical, inexpensive, and reproducible.
Clinical Disease
Syphilis is a complex systemic illness caused by the spirochete Treponema pallidum. The natural course of syphilis can be divided into five stages. The first stage is an incubation period lasting approximately 3 weeks which is followed by a primary stage characterized by a non-painful skin lesion (chancre) associated with regional lymphadenopathy and early bacteremia. This stage is followed by a secondary bacteremic or disseminated stage accompanied by generalized mucocutaneous lesions and lymphadenopathy. A period of subclinical (latent syphilis) is followed by a late or tertiary stage in a small number of patients. The latent or tertiary stage is characterized by progressive disease involving the ascending aorta and /or the central nervous (CNS), but any organ system can be involved. (1)
Disease Reporting
This is a reportable infection and positive results will be reported to the Oakland County Health Department. For more information on reportable diseases, contact the Beaumont Epidemiology Department at 248-551-4040.
Epidemiology
The vast majority of syphilis cases occur in the most sexually active age group (15-30 years old). Increased cases have been seen in heterosexuals. There has been a dramatic increase of syphilis in women and neonates. The increased number of syphilis cases has been attributed to the exchange of sex for drugs, and concomitant infections with HIV. (1)
Incubation Period
Average incubation period is 21 days (range; 3-90 days). (1, 2)
Transmission
Syphilis is transmitted by sexual contact, by passage through the placenta (congenital syphilis), by kissing, by transfusion of fresh human blood, or by accidental direct inoculation (e.g., needle stick, or when handling infected clinical material).(1)
Reference
1. Tramont,E. Treponema Pallidum (Syphilis). Mandell,G.,Bennett,J.,Dolin.R.(eds.), Principles of Infectious Diseases 4th edition New York,N.Y. 1995;2117-2133
2. American Public Health Assoc. A Manual of Tests for Syphillis. Larsen, S.A., Pope, V., Johnson, R.E., Kennedy Jr., E.J. (eds.), 9th edition, Washington, D.C. 2000.
CPT Codes
86592
LOINC: 31146-4
Contacts
Special Chemistry Laboratory – RO
248-551-8071
Name: Special Chemistry Laboratory – RO
Location:
Phone: 248-551-8071
Last Updated
7/21/2024
Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.